Blue-chip companies Unilever, AstraZeneca and British American Tobacco today lead a busy session for end-of-year corporate earnings.
AstraZeneca boss Pascal Soriot reported a 25% rise in revenues to $44.3 billion (£36.6 billion) and said he expects to see another year of double-digit revenue growth in 2023.
Unilever profits topped 8 billion euros (£7.1 billion) last year, partly thanks to higher prices for its consumer goods brands including Hellman’s, Domestos and Ben & Jerry’s. It warned that while inflation is tempering, there are most cost increases to come this year.
British American Tobacco revenue rose to £27.7 billion, as it announced an improved forecast for its vaping division.
